Ixekizumab efficacy and safety with and without concomitant conventional disease-modifying antirheumatic drugs (cDMARDs) in biologic DMARD (bDMARD)-naïve patients with active psoriatic arthritis (PsA): results from SPIRIT-P1
Coates, Laura C, Kishimoto, Mitsumasa, Gottlieb, Alice, Shuler, Catherine L, Lin, Chen-Yen, Lee, Chin Hyok, Mease, Philip JVolume:
3
Language:
english
Journal:
RMD Open
DOI:
10.1136/rmdopen-2017-000567
Date:
December, 2017
File:
PDF, 347 KB
english, 2017